Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 2/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | SLC18A3 | Q16572 | 4/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.35 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.35 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.34 |
| ▸ | HTR3B | O95264 | 1/20 | 0.34 |
| ▸ | HTR3A | P46098 | 1/20 | 0.34 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.34 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29450354 | 0.89 | NOTUM (0.55) | NOTUMCNR2SLC18A3SIGMAR1SLC6A2 | |
| SCHEMBL538625 | 0.89 | NOTUM (0.55) | NOTUMCNR2SLC18A3SIGMAR1SLC6A2 | |
| Iodide SCHEMBL28271700 | 0.87 | NOTUM (0.53) | NOTUMCNR2SLC18A3SIGMAR1SLC6A2 | |
| O-Xylene SCHEMBL8919296 | 0.82 | NOTUM (0.49) | NOTUMCNR2SLC18A3SIGMAR1SLC6A2 | |
| Perchlorate SCHEMBL30036059 | 0.81 | NOTUM (0.45) | NOTUMCNR2SLC6A2SLC6A4BIRC2 | |
| Perchlorate SCHEMBL30036840 | 0.80 | NOTUM (0.48) | NOTUMCNR2SLC6A2SLC6A4BIRC2 | |
| Bromobenzene SCHEMBL27896182 | 0.79 | NOTUM (0.46) | NOTUMCNR2SLC18A3SIGMAR1SLC6A2 | |
| SCHEMBL29715746 | 0.75 | NOTUM (0.41) | NOTUMCNR2SLC18A3SIGMAR1SLC6A2 | |
| SCHEMBL29715681 | 0.75 | NOTUM (0.45) | NOTUMCNR2SLC18A3SIGMAR1SLC6A2 | |
| SCHEMBL9550828 | 0.74 | NOTUM (0.45) | NOTUMCNR2SLC18A3SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240099948-A1 | Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents | COLABS INT'L CORP. (US) | 2024-03-28 | — | — | US | disclosed |
| US-11839674-B2 | Compositions comprising silicon dioxide-based particles including one or more agents | CoLabs International Corporation (US) | 2023-12-12 | — | — | US | disclosed |
| US-11724134-B2 | Compositions containing a cellulose derived capsule with a sunscreen active agent | CoLabs International Corporation (US) | 2023-08-15 | — | — | US | disclosed |
| US-11707421-B2 | Compositions containing a flexible derived capsule with an active agent | COLABS INT'L CORP. (US) | 2023-07-25 | — | — | US | disclosed |
| US-20230113098-A1 | Compositions Containing a Capsule with an Agent | COLABS INT'L CORP. (US) | 2023-04-13 | — | — | US | disclosed |
| US-11491088-B2 | Compositions containing a capsule with a moisturizing agent | CoLabs International Corporation (US) | 2022-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11707421-B2 | Compositions containing a flexible derived capsule with an active agent | CUTA, LIPE, LIPA | NOTUM 37/4885CNR2 1071/4885SLC18A3 3711/4885 |
| US-11724134-B2 | Compositions containing a cellulose derived capsule with a sunscreen active agent | CUTA, ACMSD, TYR | NOTUM 23/4885CNR2 1914/4885SLC18A3 4149/4885 |
| US-20230113098-A1 | Compositions Containing a Capsule with an Agent | LIPA, CUTA, FABP4 | NOTUM 28/4885CNR2 576/4885SLC18A3 3389/4885 |
| US-11491088-B2 | Compositions containing a capsule with a moisturizing agent | CUTA, LIPA, PLIN5 | NOTUM 28/4885CNR2 928/4885SLC18A3 3677/4885 |
| US-20240099948-A1 | Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents | MSN, LIPE, CUTA | NOTUM 164/4885CNR2 3634/4885SLC18A3 4385/4885 |
| US-11839674-B2 | Compositions comprising silicon dioxide-based particles including one or more agents | MSN, LIPE, CUTA | NOTUM 167/4885CNR2 3708/4885SLC18A3 4425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.